Literature DB >> 16020876

Gamma-glutamyl transferase and metabolic risk factors for cardiovascular disease.

Hidenari Sakuta1, Takashi Suzuki, Hiroko Yasuda, Teizo Ito.   

Abstract

OBJECTIVE: To elucidate the mechanism of the reported association between serum gamma-glutamyl transferase (GGT) activity and cardiovascular mortality.
METHODS: Cross-sectional analysis of the relationship between serum GGT activity and the risk factors for cardiovascular disease was performed. PATIENTS AND MATERIALS: Middle-aged Japanese male personnel of the Self-Defense Forces who underwent retirement check-up.
RESULTS: Serum GGT activity was associated with total cholesterol, triglyceride, fasting plasma glucose, total homocysteine and systolic blood pressure. The association remained in the analysis adjusted for possible confounders including cigarette smoking, ethanol consumption and body mass index.
CONCLUSION: The observed association between serum GGT and cardiovascular risk factors may partly explain the reported relationship between serum GGT activity and cardiovascular disease. Serum GGT activity may be regarded as a marker of cardiovascular risk factors or oxidative stress rather than a mere indicator of excessive ethanol consumption or obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020876     DOI: 10.2169/internalmedicine.44.538

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Quo vadis: from oxidative stress to gamma-glutamyltransferase upregulation to mortality.

Authors:  Rohini Mehta; Aybike Birerdinc; Zobair Younossi
Journal:  J Clin Exp Hepatol       Date:  2013-03

2.  Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels.

Authors:  Stéphanie Badiou; Hélène Breton; Hélène Peyriere; Virginie Charasson; Arielle Crespel; Philippe Gelisse; Jean-Paul Cristol; Dominique Hillaire-Buys
Journal:  Eur J Clin Pharmacol       Date:  2007-10-31       Impact factor: 2.953

3.  The Relationship between Serum Gamma-glutamyltransferase Level and Overweight in Korean Urban Children.

Authors:  Young-Gyu Cho; Kyung-Hee Park; Chan-Won Kim; Yang-Im Hur
Journal:  Korean J Fam Med       Date:  2011-03-31

4.  Gamma-glutamyl-transferase is associated with incident hip fractures in women and men ≥ 50 years: a large population-based cohort study.

Authors:  W Brozek; H Ulmer; A Pompella; G Nagel; A Leiherer; O Preyer; H Concin; E Zitt
Journal:  Osteoporos Int       Date:  2022-01-20       Impact factor: 5.071

5.  Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis.

Authors:  Hongcai Yang; Yi Yang; Jianping Dou; Rui Cui; Zhigang Cheng; Zhiyu Han; Fangyi Liu; Xiaoling Yu; Xiang Zhou; Jie Yu; Ping Liang
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

6.  The association between serum liver enzymes and cancer mortality.

Authors:  Somaya Albhaisi; Rehan Qayyum
Journal:  Clin Exp Med       Date:  2021-07-08       Impact factor: 3.984

7.  NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies effects of cigarette smoking on risk of elevated levels of serum liver enzyme in male Japanese health check-up examinees: a cross-sectional study.

Authors:  Akatsuki Kokaze; Masao Yoshida; Mamoru Ishikawa; Naomi Matsunaga; Kanae Karita; Tadahiro Ohtsu; Hirotaka Ochiai; Takako Shirasawa; Hinako Nanri; Yuta Baba; Hiromi Hoshino; Yutaka Takashima
Journal:  Tob Induc Dis       Date:  2014-07-10       Impact factor: 2.600

8.  Mitochondrial DNA 5178 C/A polymorphism modulates the effects of coffee consumption on elevated levels of serum liver enzymes in male Japanese health check-up examinees: an exploratory cross-sectional study.

Authors:  Akatsuki Kokaze; Masao Yoshida; Mamoru Ishikawa; Naomi Matsunaga; Kanae Karita; Hirotaka Ochiai; Takako Shirasawa; Hinako Nanri; Kiyomi Mitsui; Hiromi Hoshimo; Yutaka Takashima
Journal:  J Physiol Anthropol       Date:  2016-06-04       Impact factor: 2.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.